Supply Chain Intelligence

Roivant Sciences Ltd. Supply Chain

ROIV supply chain intelligence for Roivant Sciences Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ROIV ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
4Customers
2Debt Items
20Related Chains

Roivant Sciences Ltd. Suppliers

TickerNameConfidenceEvidence
ARBUTUS ARBUTUS 90% The Company holds an investment in Arbutus in the form of 38,847,462 common shares of Arbutus.
DATAVANT DATAVANT 85% As of December 31, 2025 and March 31, 2025, the most significant of these were the Company's investments in Arbutus and Datavant, which are accounted for using the fair value option.
OGN Organon & Co. 72% all, which could negatively affect our capacity for certain strategic transactions or our ability to make other important investments. In addition, high levels of inflation and interest rate fluctuat…
OGN Organon & Co. 72% Reciprocal relationship from OGN graph: Reciprocal relationship from ROIV graph: Reciprocal relationship from OGN graph: Reciprocal relationship from ROIV graph: Reciprocal relationship from OGN grap…

Roivant Sciences Ltd. Customers

TickerNameConfidenceEvidence
SUMITOMO-PHARMA-CO-LTD SUMITOMO-PHARMA-CO-LTD 80% In April 2024, pursuant to this share repurchase program, we entered into a share repurchase agreement with Sumitomo Pharma Co., Ltd. ("Sumitomo") and repurchased all 71,251,083 common shares held by S
IMVT Immunovant, Inc. 72% Reciprocal relationship from IMVT graph: Reciprocal relationship from ROIV graph: Reciprocal relationship from IMVT graph: data from our clinical trials that we announce or publish from time to time …
OGN Organon & Co. 72% of any renegotiated trade agreements, nor can we determine the impact they may have on our business. Any such changes could have a material adverse effect on our business, financial condition and res…
OGN Organon & Co. 72% Reciprocal relationship from OGN graph: Reciprocal relationship from ROIV graph: of any renegotiated trade agreements, nor can we determine the impact they may have on our business. Any such changes …

Roivant Sciences Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ROIV-DEBT-12255 Warrants outstanding: 0.01 90% xbrl warrant detail from xbrl 2025-03-31.
ROIV-DEBT Debt stack $108.9M 90% Market cache reports total debt of $108.9M.

Roivant Sciences Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Roivant Sciences Ltd..

Roivant Sciences Ltd. Ownership

HolderNameConfidenceEvidence
ROIV-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 443 tracked holders.

Roivant Sciences Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
OGN Organon & Co. 100.00 1 ['customer', 'supplier']
MGNX MacroGenics, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
AUTL Autolus Therapeutics plc 100.00 2
IMVT Immunovant, Inc. 100.00 1 ['customer']
COP ConocoPhillips 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
MC Moelis & Company 100.00 2
BPAQF BP p.l.c. 100.00 2
MRVI Maravai LifeSciences Holdings, Inc. 50.00 2
MTNB Matinas BioPharma Holdings, Inc. 50.00 2
KMC KMC 50.00 2
CMRE Costamare Inc. 50.00 2
ORANY ORANGE 50.00 2
EVAX Evaxion A/S 50.00 2
TNXP Tonix Pharmaceuticals Holding Corp. 50.00 2
SMMT Summit Therapeutics Inc. 50.00 2
ARGX argenx SE 50.00 2
MRK Merck & Co., Inc. 50.00 2
SNYNF Sanofi 50.00 2
View ROIV supply chain intel →

Explore the full interactive supply chain map for Roivant Sciences Ltd..

Open ROIV supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map